Net Loss Per Share Attributable to Guardant Health, Inc. Common Stockholders

3 Months Ended

Mar. 31, 2020

Net Loss Per Share Attributable to Guardant Health, Inc. Common Stockholders

The following table sets forth the computation of the basic and diluted net loss per share attributable to Guardant Health, Inc. common stockholders:



	Three Months Ended March 31,
	2020			2019

	(unaudited)
	(in thousands, except per share data)
Net loss	$	(31,829	)	$	(21,351	)
Adjustment of redeemable noncontrolling interest	4,100			(4,700		)
Net loss attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(27,729	)	$	(26,051	)
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	$	(0.29	)	$	(0.30	)
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic and diluted	94,382			85,935

Since the Company was in a loss position for all periods presented, basic net loss per share attributable to Guardant Health, Inc. common stockholders is the same as diluted net loss per share attributable to Guardant Health, Inc. common stockholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to Guardant Health, Inc. common stockholders for the periods presented as they had an anti-dilutive effect:



	Three Months Ended March 31,
	2020	2019

	(unaudited)
	(in thousands)
Stock options issued and outstanding	4,345	7,503
Restricted stock units	495	78
ESPP obligation	43	59
Common stock subject to repurchase	22	41
Total	4,905	7,681